Stock In Spotlight: Abbott Laboratories (NYSE:ABT)

Adjust Comment Print

Royal Retail Bank Of Canada holds 0% or 184,040 shares. Abbott Labs now has $96.25 billion valuation. About shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since October 11, 2016 and is uptrending. Asset Mgmt Incorporated reported 0.18% of its portfolio in Abbott Laboratories (NYSE:ABT). Security National Trust Co sold 18,979 shares as General Electric Co (GE)'s stock declined 7.64%. Cna Corp has 8,620 shares. It has underperformed by 12.52% the S&P500. Abbott Laboratories presently has an average rating of "Buy" and a consensus target price of $54.94. Therefore 88% are positive.

According to Finviz reported data, The SMA20 of the stock is at 2.61 percent, SMA50 is 6.44 percent, while SMA200 is 17.49 percent. BTIG Research maintained the shares of ABT in report on Saturday, August 29 with "Buy" rating. The stock of General Electric Company (NYSE:GE) has "Buy" rating given on Monday, July 10 by RBC Capital Markets. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation. Maxim Group maintained it with "Buy" rating and $59 target in Thursday, October 27 report. The company was maintained on Saturday, August 29 by Deutsche Bank. Stifel Nicolaus has "Buy" rating and $58.0 target. The firm has "Neutral" rating by Bank of America given on Wednesday, April 26.

Investors sentiment decreased to 0.88 in Q2 2017. Its down 0.36, from 0.97 in 2017Q1. Bankshares invested in 0.83% or 156,493 shares. 11 funds opened positions while 9 raised stakes. D E Shaw And Com reported 256,530 shares or 0.02% of all its holdings. Fifth Third Bancorp stated it has 1.1% in General Electric Company (NYSE:GE). Moreover, Piedmont Inv Ltd Liability Co has 0.41% invested in Abbott Laboratories (NYSE:ABT). John G Ullman & Assocs, a New York-based fund reported 275,927 shares. Rhumbline Advisers, a Massachusetts-based fund reported 56,264 shares. Coho Prns Ltd reported 0.02% in General Electric Company (NYSE:GE). Credit Agricole S A invested in 0% or 24,702 shares. Hbk Sorce Advisory Limited Liability Corp holds 159,613 shares. Veritable Lp reported 26,180 shares stake. O Reilly Automotive Inc New (NASDAQ:ORLY) was reduced too. Spc Fincl has invested 0.3% of its portfolio in General Electric Company (NYSE:GE). Riverhead Capital Mgmt Ltd Liability stated it has 0% in Diamond Offshore Drilling Inc (NYSE:DO).


Analysts await General Electric Company (NYSE:GE) to report earnings on October, 20 before the open. ABT's profit will be $1.11B for 20.90 P/E if the $0.65 EPS becomes a reality. After $0.28 actual EPS reported by General Electric Company for the previous quarter, Wall Street now forecasts 78.57% EPS growth.

Since May 22, 2017, it had 1 buying transaction, and 0 insider sales for $54,660 activity. PITTAWAY DAVID BRUCE had bought 400 shares worth $23,288.

Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.75, from 1.63 in 2017Q1. It turned negative, as 69 investors sold ABT shares while 545 reduced holdings. New Mexico Educational Retirement Board invested 0.38% of its portfolio in Abbott Laboratories (NYSE:ABT). Partner Mngmt Limited Partnership, California-based fund reported 24,895 shares. Trading volume for Abbott Laboratories was 4.94 Million in its previous trading session. It fall, as 19 investors sold Regulus Therapeutics Inc shares while 14 reduced holdings. Of Virginia Va accumulated 0.27% or 36,131 shares. Mcf Limited Liability Company owns 3,282 shares. The ROA for Abbott Laboratories tells us exactly what earnings were generated from the invested capital. About shares traded. Cheesecake Factory Inc (NASDAQ:CAKE) has risen 21.63% since October 11, 2016 and is uptrending. Rice Hall James Assocs Lc owns 408,952 shares. Horan Advsr Limited Co has invested 1.65% in Abbott Laboratories (NYSE:ABT).


Abbott Laboratories (NYSE:ABT) last issued its quarterly earnings results on Thursday, July 20th. Systematic Finance Mngmt L P holds 0.03% or 34,400 shares. Natixis reported 0% stake. The EPS growth for the past five (5) years shows a value of 0.00%, whilst the EPS value for the next five (5) years shows a figure of 11.29%. DO's profit would be $32.05M giving it 15.84 P/E if the $0.23 EPS is correct.

Wall Street analysts, on average, are forecasting the company's EPS to be 0.65, compared to 0.59 reported in the same quarter a year ago.

Since June 15, 2017, it had 0 insider purchases, and 1 sale for $26,482 activity. $26,482 worth of Abbott Laboratories (NYSE:ABT) was sold by Watkin Jared on Thursday, June 15. Zacks Investment Research raised shares of Abbott Laboratories from a "hold" rating to a "buy" rating and set a $61.00 price target for the company in a research note on Tuesday. Therefore 58% are positive. Regulus Therapeutics had 23 analyst reports since August 5, 2015 according to SRatingsIntel. Edward Jones upgraded Abbott Laboratories (NYSE:ABT) on Tuesday, June 21 to "Buy" rating. Jefferies downgraded Cheesecake Factory Inc (NASDAQ:CAKE) on Wednesday, January 4 to "Underperform" rating. The stock of Abbott Laboratories (NYSE:ABT) has "Hold" rating given on Monday, July 10 by BMO Capital Markets. Barclays Capital maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, April 20. The firm has "Buy" rating given on Thursday, September 28 by Wells Fargo. The firm has "Buy" rating given on Monday, September 11 by Goldman Sachs. William Blair downgraded the stock to "Market Perform" rating in Friday, January 29 report. On Monday, October 12 the stock rating was upgraded by Deutsche Bank to "Buy". On Friday, October 6 the stock rating was maintained by Keefe Bruyette & Woods with "Hold".


Comments